chd10q1q2009.htm
 


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
     

FORM 10-Q

     

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 27, 2009

Commission file number 1-10585
     

CHURCH & DWIGHT CO., INC.
(Exact name of registrant as specified in its charter)
     

Delaware
13-4996950
     (State or other jurisdiction
(I.R.S. Employer Identification No.)
     of incorporation or organization)
 

469 North Harrison Street, Princeton, N.J. 08543-5297
(Address of principal executive office)

Registrant's telephone number, including area code:  (609) 683-5900
     

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding twelve months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.   Yes x   No o
 
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or smaller reporting company.  See definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.
 
 Large accelerated filer      x    Accelerated filer  o  
 Non-accelerated filer  o    Smaller reporting company  o  
 
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act) Yes o No x
 
As of May 1, 2009, there were 70,221,318 shares of Common Stock outstanding.
 



 
 
TABLE OF CONTENTS
 
PART I
 
Item
 
Page
1.
3
2.
21
3.
26
4.
27
 
 
PART II
 
1.
28
1A.
Risk Factors       
28
4.
28
6.
29
 

PART I - FINANCIAL INFORMATION

ITEM 1:   FINANCIAL STATEMENTS

CHURCH & DWIGHT CO., INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF INCOME
(Unaudited)

 
   
Three Months Ended
 
   
March 27,
   
March 28,
 
(Dollars in thousands, except per share data)
 
2009
   
2008
 
Net Sales
  $ 580,867     $ 552,867  
Cost of sales
    331,509       328,761  
Gross Profit
    249,358       224,106  
Marketing expenses
    66,373       53,485  
Selling, general and administrative expenses
    78,325       77,859  
Income from Operations
    104,660       92,762  
Equity in earnings of affiliates
    2,705       2,380  
Investment earnings
    392       2,569  
Other income (expense), net
    484       2,198  
Interest expense
    (8,749 )     (12,505 )
Income before Income Taxes
    99,492       87,404  
Income taxes
    36,916       31,211  
Net Income
    62,576       56,193  
Noncontrolling interest
    7       2  
Net Income attributable to Church & Dwight Co., Inc.
  $ 62,569     $ 56,191  
Weighted average shares outstanding - Basic
    70,234       66,343  
Weighted average shares outstanding - Diluted
    71,312       70,817  
Net income per share - Basic
  $ 0.89     $ 0.85  
Net income per share - Diluted
  $ 0.88     $ 0.81  
Cash dividends per share
  $ 0.09     $ 0.08  

See Notes to Condensed Consolidated Financial Statements.
 
 
CHURCH & DWIGHT CO., INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS
(Unaudited)

   
March 27,
   
December 31,
 
(Dollars in thousands, except per share data)
 
2009
   
2008
 
Assets
           
Current Assets
           
Cash and cash equivalents
  $ 280,241     $ 197,999  
Accounts receivable, less allowances of $5,567 and $5,427
    216,469       211,194  
Inventories
    199,882       198,893  
Deferred income taxes
    17,114       15,107  
Prepaid expenses
    11,648       10,234  
Other current assets
    31,476       31,694  
Total Current Assets
    756,830       665,121  
Property, Plant and Equipment, Net
    398,965       384,519  
Equity Investment in Affiliates
    9,821       10,061  
Tradenames and Other Intangibles
    803,907       810,173  
Goodwill
    845,412       845,230  
Other Assets
    85,681       86,334  
Total Assets
  $ 2,900,616     $ 2,801,438  
Liabilities and Stockholders' Equity
               
Current Liabilities
               
Short-term borrowings
  $ 35,268     $ 3,248  
Accounts payable and accrued expenses
    307,804       310,622  
Current portion of long-term debt
    95,631       71,491  
Income taxes payable
    20,906       1,760  
Total Current Liabilities
    459,609       387,121  
Long-term Debt
    740,282       781,402  
Deferred Income Taxes
    183,802       171,981  
Deferred and Other Long Term Liabilities
    93,613       93,430  
Pension, Postretirement and Postemployment Benefits
    32,833       35,799  
Total Liabilities
    1,510,139       1,469,733  
Commitments and Contingencies
               
Stockholders' Equity
               
Preferred Stock-$1.00 par value
               
    Authorized 2,500,000 shares, none issued
    -       -  
Common Stock-$1.00 par value
               
    Authorized 300,000,000 shares, issued 73,213,775 shares
    73,214       73,214  
Additional paid-in capital
    257,064       252,129  
Retained earnings
    1,120,188       1,063,928  
Accumulated other comprehensive loss
    (24,017 )     (20,454 )
Common stock in treasury, at cost:
               
    3,025,682  shares in 2009 and 3,140,931 shares in 2008
    (36,168 )     (37,304 )
Total Church & Dwight Co., Inc. Stockholders' Equity
    1,390,281       1,331,513  
Noncontrolling interest
    196       192  
Total Stockholders' Equity
    1,390,477       1,331,705  
Total Liabilities and Stockholders’ Equity
  $ 2,900,616     $ 2,801,438  
 
See Notes to Condensed Consolidated Financial Statements.
 
 
CHURCH & DWIGHT CO., INC. AND SUBSIDIARIES
 
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOW
(Unaudited)
 
   
Three Months Ended
 
   
March 27,
   
March 28,
 
(Dollars in thousands)
 
2009
   
2008
 
Cash Flow From Operating Activities
           
Net Income
  $ 62,569     $ 56,191  
Adjustments to reconcile net income to net cash provided by operating activities:
               
     Depreciation and amortization
    21,670       15,212  
     Equity in earnings of affiliates
    (2,705 )     (2,380 )
     Distributions from unconsolidated affiliates
    2,945       2,564  
     Deferred income taxes
    10,106       2,103  
     Asset impairment charges and other asset write-offs
    -       5,626  
     Gain on sale of assets
    -       (3,005 )
     Non cash compensation expense
    2,707       2,424  
     Unrealized foreign exchange gain and other
    (379 )     (2,558 )
Change in assets and liabilities:
               
     Accounts receivable
    (7,980 )     3,436  
     Inventories
    (2,348 )     (3,549 )
     Prepaid expenses
    (1,466 )     (2,409 )
     Accounts payable and accrued expenses
    (11,780 )     (30,473 )
     Income taxes payable
    20,413       20,936  
     Excess tax benefit on stock options exercised
    (936 )     (1,872 )
     Other liabilities
    (835 )     477  
Net Cash Provided By Operating Activities
    91,981       62,723  
Cash Flow From Investing Activities
               
Proceeds from sale of assets
    -       9,620  
Additions to property, plant and equipment
    (21,281 )     (6,283 )
Proceeds from note receivable
    1,324       1,263  
Contingent acquisition payments
    (241 )     (305 )
Change in other long-term assets
    (417 )     (111 )
Net Cash (Used In) Provided by Investing Activities
    (20,615 )     4,184  
Cash Flow From Financing Activities
               
Long-term debt repayment
    (16,979 )     (8,453 )
Short-term debt borrowings, net
    31,434       (100,000 )
Bank overdrafts
    561       293  
Proceeds from stock options exercised
    2,071       2,761  
Excess tax benefit on stock options exercised
    936       1,872  
Payment of cash dividends
    (6,309 )     (5,307 )
Net Cash Provided by (Used In) Financing Activities
    11,714       (108,834 )
Effect of exchange rate changes on cash and cash equivalents
    (838 )     180  
Net Change In Cash and Cash Equivalents
    82,242       (41,747 )
Cash and Cash Equivalents at Beginning of Period
    197,999       249,809  
Cash and Cash Equivalents at End of Period
  $ 280,241     $ 208,062  
 
See Notes to Condensed Consolidated Financial Statements
 
 
CHURCH & DWIGHT CO., INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOW-CONTINUED
(Unaudited)

   
Three Months Ended
 
   
March 27,
   
March 28,
 
(Dollars in thousands)  
2009
   
2008
 
Cash paid during the year for:
           
     Interest (net of amounts capitalized)
  $ 2,790     $ 9,270  
     Income taxes
  $ 5,349     $ 7,584  
Supplemental disclosure of non-cash investing activities:
               
     Property, plant and equipment expenditures included in Accounts Payable
  $ 12,324     $ 932  

See Notes to Condensed Consolidated Financial Statements.
 
 
CHURCH & DWIGHT CO., INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS’ EQUITY

For the Three Months Ended March 27, 2009
(Unaudited)
 
   
Number of Shares
   
Amounts
 
               
Church & Dwight Co., Inc. Stockholders' Equity
       
                                       
Accumulated
       
                           
Additional
         
Other
       
   
Common
   
Treasury
   
Common
   
Treasury
   
Paid-In
   
Retained
   
Comprehensive
   
Noncontrolling
 
(in thousands)
 
Stock
   
Stock
   
Stock
   
Stock
   
Capital
   
Earnings
   
Income (Loss)
   
Interest
 
December 31, 2008
    73,214       (3,141 )   $ 73,214     $ (37,304 )   $ 252,129     $ 1,063,928     $ (20,454 )   $ 192  
Net income
    -       -       -       -       -       62,569       -       7  
Translation adjustments
    -       -       -       -       -       -       (4,502 )     (3 )
Derivative agreements,
                                                               
net of taxes of $485
    -       -       -       -       -       -       948       -  
Defined Benefit Plans,
                                                               
net of taxes of $9
    -       -       -       -       -       -       (9 )     -  
Comprehensive income
                                                               
Cash dividends
    -       -       -       -       -       (6,309 )     -       -  
Stock purchases
    -       -       -       -       -       -       -       -  
Stock based compensation
                                                               
expense and stock option
                                                               
plan transactions including
                                                               
related income tax benefits of $1,293
    -       105       -       1,031       4,757       -       -       -  
Other stock issuances
    -       10       -       105       178       -       -       -  
March 27, 2009
    73,214       (3,026 )   $ 73,214     $ (36,168 )   $ 257,064     $ 1,120,188     $ (24,017 )   $ 196  
 
See Notes to Condensed Consolidated Financial Statements.
 
 
CHURCH & DWIGHT CO., INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

1.  
 Basis of Presentation
 
The condensed consolidated balance sheets as of March 27, 2009 and December 31, 2008, the condensed consolidated statements of income for the three months ended March 27, 2009 and March 28, 2008, the condensed consolidated statements of cash flow for the three months ended March 27, 2009 and March 28, 2008 and the condensed consolidated statement of stockholders’ equity for the three months ended March 27, 2009 have been prepared by the Company. In the opinion of management, all adjustments (which include only normal recurring adjustments) necessary to present fairly the financial position at March 27, 2009 and results of operations and cash flow for all periods presented have been made.

Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles have been condensed or omitted.  These condensed consolidated financial statements should be read in conjunction with the financial statements and notes thereto included in the Company's annual report on Form 10-K for the year ended December 31, 2008.  The results of operations for the three month period ended March 27, 2009 are not necessarily indicative of the operating results for the full year.

The Company’s fiscal year begins on January 1st and ends on December 31st.  Quarterly periods are based on a 4 weeks - 4 weeks - 5 weeks methodology.  As a result, the first quarter can include a partial or expanded week in the first four week period of the quarter.  Similarly, the last five week period in the fourth quarter could include a partial or expanded week.  Certain subsidiaries operating outside of North America are included for periods beginning and ending one month prior to the period presented, which enables timely processing of consolidating results.  There were no material intervening events that occurred with respect to these subsidiaries in the one month period prior to the period presented.

The Company incurred research and development expenses in the first quarter of 2009 and 2008 of $10.9 million and $12.0 million, respectively.  These expenses are included in selling, general and administrative expenses.

2.  
Inventories consist of the following:

   
March 27,
   
December 31,
 
(In thousands)
 
2009
   
2008
 
Raw materials and supplies
  $ 55,529     $ 52,850  
Work in process
    10,070       9,147  
Finished goods
    134,283       136,896  
Total
  $ 199,882     $ 198,893  
 
 
3.  
 
Property, Plant and Equipment consist of the following:

   
March 27,
   
December 31,
 
(In thousands)
 
2009
   
2008
 
Land
  $ 25,579     $ 25,659  
Buildings and improvements
    143,531       143,590  
Machinery and equipment
    420,628       421,012  
Office equipment and other assets
    38,496       41,169  
Software
    36,692       36,729  
Mineral rights
    1,158       1,146  
Construction in progress
    89,976       60,949  
      756,060       730,254  
Less accumulated depreciation and amortization
    357,095       345,735  
Net Property, Plant and Equipment
  $ 398,965     $ 384,519  

Depreciation and amortization of property, plant and equipment amounted to $14.5 million and $9.5 million for the three months ended March 27, 2009 and March 28, 2008, respectively. Interest charges capitalized in connection with construction projects were $0.5 million and $0.1 million for the three months ended March 27, 2009 and March 28, 2008, respectively.

During the second quarter of 2008, the Company announced it will be closing its North Brunswick, New Jersey facility in 2009 and has been recording accelerated depreciation charges on those facilities.  The accelerated depreciation charge, which was $4.5 million in the first quarter of 2009 (see Note 16), is included in total depreciation expense.

4.  
Earnings Per Share (“EPS”)

Basic EPS is calculated based on income available to common shareholders and the weighted-average number of shares outstanding during the reported period.  Diluted EPS includes additional dilution from potential common stock issuable pursuant to the exercise of stock options outstanding. The following table sets forth a reconciliation of the weighted average number of common shares outstanding to the weighted average number of shares outstanding on a diluted basis.
 
   
Three Months Ended
 
   
March 27,
   
March 28,
 
(In thousands)
 
2009
   
2008
 
Weighted average common shares outstanding - basic
    70,234       66,343  
Dilutive effect of stock options
    1,078       1,240  
Dilutive effect of convertible debt
    -       3,234  
Weighted average common shares outstanding - diluted
    71,312       70,817  
Antidilutive stock options outstanding
    712       490  
 
 
5.  
 
Stock-Based Compensation

A summary of option activity during the three months ended March 27, 2009 is as follows:
 
               
Weighted-
       
         
Weighted-
   
Average
   
Aggregate
 
         
Average
   
Remaining
   
Intrinsic
 
   
Options
   
Exercise
   
Contractual
   
Value
 
     
(000)
   
Price
   
Term
    $
(000)
 
Outstanding at January 1, 2009
    4,258     $ 35.42                
Exercised
    (105 )     19.22                
Cancelled
    (19 )     47.98                
Outstanding at March 27, 2009
    4,134       35.75       6.1     $ 67,653  
Exercisable at March 27, 2009
    2,097     $ 25.88       4.3     $ 53,583  
 
   
Three Months Ended
 
   
March 27,
   
March 28,
 
(In millions)
 
2009
   
2008
 
Intrinsic Value of Stock Options Exercised
  $ 3.3     $ 6.0  
Stock Compensation Expense Related to Stock Option Awards
  $ 2.4     $   2.3  

Stock compensation expense related to restricted stock awards was $0.2 million in the first quarter of 2009. This expense amounted to $0.1 million for the same period of 2008.
 
6.  
Fair Value of Certain Instruments
 
Statement of Financial Accounting Standards (“SFAS”) No. 157, “Fair Value Measurements,” establishes a hierarchy that prioritizes the inputs (generally, assumptions that market participants would use in pricing an asset or liability) used to measure fair value based on the quality and reliability of the information provided by the inputs, as follows:

Level 1: Quoted market prices in active markets for identical assets or liabilities.
Level 2: Observable market based inputs or unobservable inputs that are corroborated by market data.
Level 3: Unobservable inputs that are not corroborated by market data.

 
The following table summarizes the carrying amounts and fair values of certain assets and liabilities:

   
March 27, 2009
 
(In thousands)
 
Carrying Amount
   
Quoted Prices in Active Markets for Identical Assets (Level 1)
   
Significant Other Observable Inputs (Level 2)
   
Significant Unobservable Inputs (Level 3)
 
Assets
                       
Foreign exchange contracts
  $ 523     $ -     $ 523     $ -  
Liabilities
                               
Interest rate collars
  $ 6,953     $ -     $ 6,953     $ -  
Diesel fuel contract
    3,495       -       3,495       -  
    $ 10,448     $ -     $ 10,448     $ -  

The fair value of the foreign exchange contracts are based on observable forward rates in commodity quoted intervals for the full term of the contract.

The fair value of the diesel fuel contracts is based on home heating oil future prices for the duration of the contract.

The fair value for the interest rate collars was derived using the forward three month LIBOR curve for the duration of the respective collars and a credit valuation adjustment.

7.  
Derivative Instruments

Changes in interest rates, foreign exchange rates, the Company's common stock, and commodity prices expose the Company to market risk. The Company manages these risks by the use of derivative instruments, such as cash flow hedges, diesel hedge contracts, equity derivatives and foreign exchange forward contracts.  As a matter of policy, the Company does not use derivatives for trading or speculative purposes.

On January 1, 2009, the Company adopted FAS No. 161 “Disclosures about Derivative Instruments and Hedging Activities, an amendment of FASB Statement No. 133.”   FAS No. 161 requires enhanced disclosure of derivatives and hedging activities on an interim and annual basis. The guidance seeks to improve the transparency of financial reporting through enhanced disclosures on: (a) how and why an entity uses derivative instruments; (b) how derivative instruments and related hedged items are accounted for under FAS No. 133, “Accounting for Derivative Instruments and Hedging Activities,” and its related interpretations; and (c) how derivative instruments and related hedged items affect an entity’s financial position, financial performance, and cash flows.

The designation of a derivative instrument as a hedge and its ability to meet the FAS No. 133 hedge accounting criteria determines how the change in fair value of the derivative instrument will be reflected in the Condensed Consolidated Financial Statements. A derivative qualifies for hedge accounting if, at inception, the derivative is expected to be highly effective in offsetting the hedged underlying’s cash flows or fair value and the documentation standards of FAS No. 133 are fulfilled at the time the Company enters into the derivative contract. A hedge is designated as a cash flow hedge, fair value hedge, or a net investment in foreign operations hedge based on the exposure being hedged. The asset or liability value of the derivative will change in tandem with its fair value. Changes in fair value, for the effective portion of qualifying hedges, are recorded in other comprehensive income (“OCI”). The derivative’s gain or loss is released from OCI to match the timing of the hedged underlying’s cash flows effect on earnings.

The Company reviews the effectiveness of its hedging instruments on a quarterly basis and recognizes in earnings current period hedge ineffectiveness and discontinues hedge accounting for any derivative instrument that is no longer considered to be highly effective. Changes in fair value for derivatives not designated as hedges or those not qualifying for hedge accounting are recognized in current period earnings. Upon termination of cash flow hedges, the Company reclassifies gains and losses from other comprehensive income based on the timing of the underlying cash flows, unless the termination results from the failure of the intended transaction to occur in the expected timeframe. Such untimely transactions require us to immediately recognize in earnings gains and losses previously recorded in other comprehensive income.

 
During the first quarter of 2009, the Company used the following derivative instruments to mitigate risk:
 
Cash Flow Hedges

The Company has two cash flow hedge agreements, each covering $100.0 million of zero cost collars, one effective as of September 29, 2006, and the other effective as of December 29, 2006, to reduce the impact of interest rate fluctuations on its term loan debt.  The hedge agreements have terms of five and three years, respectively, each with a cap of 6.50% and a floor of 3.57%. The Company recorded a charge to interest expense of $1.0 million in the first quarter of 2009 with respect to the hedge agreements and estimates it will recognize approximately $2.8 million in interest expense in the remainder of 2009.  Changes in the fair value of cash flow hedge agreements are recorded in Accumulated Other Comprehensive Income on the balance sheet.

Foreign Currency

The Company is subject to exposure from fluctuations in foreign currency exchange rates, primarily U.S. Dollar/Euro, U.S. Dollar/British Pound, U.S. Dollar/Canadian Dollar, U.S. Dollar/Mexican Peso, U.S. Dollar/Australian Dollar, U.S. Dollar/Brazilian Real and U.S. Dollar/Chinese Yuan.

The Company, from time to time, enters into forward exchange contracts to hedge anticipated but not yet committed sales or purchases denominated in the U.S. Dollar, Canadian dollar, British pound and Euro. During the fourth quarter of 2008 and the first quarter of 2009, the Company’s Canadian subsidiary entered into forward exchange contracts to protect the Company from the risk that dollar net cash outflows would be adversely affected by changes in exchange rates.  The contracts expire by the end of 2009. The face value of the unexpired contracts as of March 27, 2009 totaled $13.5 million.  The contracts qualified as foreign currency cash flow hedges in accordance with SFAS No. 133, and, therefore, changes in the fair value through the end of the first quarter 2009 were marked to market and recorded as Other Comprehensive Income. The gain recorded, net of deferred taxes, was approximately $0.4 million.

Derivatives not Designated as Hedging Instruments Under FAS No. 133

Diesel Fuel Hedges

The Company uses independent freight carriers to deliver its products.  These carriers charge the Company a basic rate per mile that is subject to a mileage surcharge for diesel fuel price increases.  In July 2008 and April 2009, in response to increasing fuel prices and a concomitant increase in mileage surcharges, the Company entered into agreements with two providers to hedge approximately 36% if its notional diesel fuel requirements for 2009 and approximately 15% of its 2010 requirements.  It is the Company’s policy to use the hedges to mitigate the volatility of diesel fuel prices and related fuel surcharges, and not to speculate in the future price of diesel fuel.  The hedge agreements are designed to add stability to the Company’s product costs, enabling the Company to make pricing decisions and lessen the economic impact of abrupt changes in diesel fuel prices over the term of the contract.

Because the diesel hedge agreements do not qualify for hedge accounting under SFAS No. 133, the Company is required to mark the agreements to market throughout the life of the agreements.  The change in the market value of the hedge agreements resulted in a $0.1 million loss for the first quarter of 2009, which is reflected in cost of sales.  If future diesel prices were to change by $0.10 per gallon, the impact on the Company’s financial statements for the remainder of 2009 due to the hedge agreements would be approximately $0.2 million.
 
Equity Derivatives

The Company has entered into equity derivative contracts of its own stock in order to minimize the impact on earnings resulting from fluctuations in the liability to plan participants for contributions designated to notional investments in Company stock under the Company’s deferred compensation plan as a result of changes in quoted fair values.

 
The following tables summarize the fair value of our derivative instruments, the effect of derivative instruments on our Condensed Consolidated Statements of Income and on comprehensive income, and the amounts reclassified from other comprehensive income:
 
       
Fair Value at
   
Fair Value at
 
(In millions)
 
Balance Sheet Location
 
March 27, 2009
   
December 31, 2008
 
Derivatives designated as hedging instruments under FAS No. 133
               
Asset Derivatives
               
Foreign exchange contracts
 
Accounts receivable
  $ 0.5     $ 0.4  
Liability Derivatives
                   
Interest rate collars
 
Accounts payable and accrued expenses
  $ 1.8     $ -  
Interest rate collars
 
Other long-term liabilities
    5.1       7.9  
Total liabilities under FAS No. 133
      $ 6.9     $ 7.9  
Derivatives not designated as hedging instruments under FAS No. 133
                   
Asset Derivatives
                   
Equity derivatives
 
Accounts receivable
  $ 0.3     $ -  
Liability Derivatives
                   
Equity derivatives
 
Accounts payable and accrued expenses
  $ 0.7     $ 0.1  
Diesel fuel contract
 
Accounts payable and accrued expenses
    4.4       4.5  
Total liabilities outside FAS No. 133
      $ 5.1     $ 4.6  
                     
       
Amount of Gain (Loss) Recognized in Income
   
Amount of Gain (Loss) Recognized in Income
 
   
Location of Gain (Loss)
 
Three Months Ended
   
Three Months Ended
 
(In millions)
 
Recognized in Income
 
March 27, 2009
   
March 28, 2008
 
Derivatives not designated as hedging instruments under FAS No. 133
                   
Equity derivatives
 
Selling, general and administrative expenses
  $ (0.5 )   $ (0.2 )
Diesel fuel contracts
 
Cost of sales
    (0.1 )     1.9  
Total loss recognized in income
      $ (0.1 )   $ 1.7  
                     
       
Amount of Gain Recognized in OCI
   
Amount of Gain Recognized in OCI
 
       
from Derivatives
   
from Derivatives
 
       
Three Months Ended
   
Three Months Ended
 
(In millions)
     
March 27, 2009
   
March 28, 2008
 
Derivatives in FAS No. 133 cash flow hedging relationship
                   
 Foreign exchange contracts (net of taxes)
 
Other comprehensive income
  $ 0.4     $ -  
Interest rate collars (net of taxes)
 
Other comprehensive income
    0.6       2.2  
Total gain recognized in OCI
      $ 1.0     $ 2.2  
 
The amount of gain (loss) reclassified from other comprehensive income for derivitave income was immaterial for the three months ended March 27, 2009 and March 28, 2008.
 
 
8.  
 
Acquisitions

On July 7, 2008, the Company purchased substantially all of the assets and certain liabilities of Del Pharmaceuticals, Inc. (the “Orajel Acquisition”) for cash consideration of $383.4 million including fees. Products acquired from Del Pharmaceuticals, Inc. include the Orajel brand of oral analgesics and various other over-the-counter brands.  The Company paid for the acquisition with proceeds of $250.0 million in additional bank debt and with available cash.  The Company is in the process of finalizing the purchase price allocation.
 
9.  
Goodwill and Other Intangible Assets

The following table provides information related to the carrying value of all intangible assets excluding goodwill:

   
March 27, 2009
   
December 31, 2008
 
   
Gross
               
Gross
             
   
Carrying
   
Accumulated
         
Carrying
   
Accumulated
       
(In thousands)
 
Amount
   
Amortization
   
Net
   
Amount
   
Amortization
   
Net
 
Amortizable intangible assets:
 
    Tradenames
  $ 115,811     $ (40,555 )   $ 75,256     $ 115,976     $ (38,648 )   $ 77,328  
    Customer Relationships
    241,640       (27,335 )     214,305       241,640       (24,045 )     217,595  
    Patents/Formulas
    27,370       (15,778 )     11,592       27,220       (14,977 )     12,243  
    Non Compete Agreement
    1,143       (835 )     308       1,143       (807 )     336  
    Total
  $ 385,964     $ (84,503 )   $ 301,461     $ 385,979     $ (78,477 )   $ 307,502  
                                                 
Indefinite lived intangible assets - Carrying value
 
    Tradenames
  $ 502,446                     $ 502,671                  
 
Intangible amortization expense amounted to $6.1 million for the first quarter of 2009 and $4.8 million for the same period of 2008.  The increase principally reflects the customer relationship amortization related to the Orajel Acquisition. The Company estimates that intangible amortization expense will be approximately $23.0 million in each of the next five years.

The changes in the carrying amount of goodwill for the three months ended March 27, 2009 are as follows:

(In thousands)
 
Consumer
Domestic
   
Consumer
International
   
Specialty
Products
   
Total
 
Balance December 31, 2008
  $ 788,516     $ 36,486     $ 20,228     $ 845,230  
Goodwill associated with the Orajel acquisition
    13       -       -       13  
Additional contingent consideration
    169       -       -       169  
Balance March 27, 2009
  $ 788,698     $ 36,486     $ 20,228     $ 845,412  
 
 
10.  
 
Short-Term Borrowings and Long-Term Debt

Short-term borrowings and long-term debt consist of the following:

   
March 27,
   
December 31,
 
(In thousands)
 
2009
   
2008
 
Short-term borrowings
           
Securitization of accounts receivable due in February 2010
  $ 30,000     $ 1,000  
Various debt due to international banks
    5,268       2,248  
Total short-term borrowings
  $ 35,268     $ 3,248  
Long-term debt
               
Term Loan facility
  $ 585,913     $ 602,893  
Senior subordinated notes (6%) due December 22, 2012
    250,000       250,000  
Total long-term debt
    835,913       852,893  
Less: current maturities
    95,631       71,491  
Net long-term debt
  $ 740,282     $ 781,402  

The long-term debt principal payments required to be made are as follows:
 
(In thousands)
   
Due by March 2010
  $ 95,631
Due by March 2011
    171,312
Due by March 2012
    187,862
Due by December 2012
    381,108
    $ 835,913
 
During the first quarter of 2009, the Company’s net borrowings under its accounts receivable securitization facility were $29.0 million.  In the first three months of 2009, the Company repaid approximately $17.0 million of its Term Loan.
 
11.  
Comprehensive Income

The following table provides information relating to the Company’s accumulated comprehensive loss:

                     
Accumulated
 
   
Foreign
   
Defined
         
Other
 
   
Currency
   
Benefit
   
Derivative
   
Comprehensive
 
(In thousands)  
Adjustments
   
Plans
   
Agreements
   
Income (Loss)
 
Balance December 31, 2008
  $ (7,173 )   $ (8,567 )   $ (4,714 )   $ (20,454 )
Comprehensive income changes during the three months ended (net of tax of $ 494)
    (4,502 )     (9 )     948       (3,563 )
Balance March 27, 2009
  $ (11,675 )   $ (8,576 )   $ (3,766 )   $ (24,017 )
 
 
The following table provides information related to the Company’s other comprehensive income for the three months ended March 27, 2009 and March 28, 2008, respectively.
 
     Three Months Ended  
   
March 27,
   
March 28,
 
(In thousands)
 
2009
   
2008
 
Net Income
  $ 62,569     $ 56,191  
Other Comprehensive Income, Net of Tax:
               
     Foreign Exchange Translation Adjustments
    (4,502 )     (2,880 )
     Derivative Agreements
    948       (2,325 )
     Defined Benefit Plan Adjustments
    (9 )     -  
Comprehensive Income
    59,006       50,986  
Comprehensive Income attributable to the noncontrolling interest
    4       2  
Comprehensive Income attributable to Church & Dwight Co., Inc.
  $ 59,010     $ 50,988  

12.  
Pension and Postretirement Plans

The following table provides information regarding the net periodic benefit cost for the Company’s pension and postretirement plans for the three months ended March 27, 2009 and March 28, 2008:

   
Pension Costs
 
   
Three Months Ended
 
   
March 27,
   
March 28,
 
(In thousands)
 
2009
   
2008
 
Components of Net Periodic Benefit Cost:
           
     Service cost
  $ 388     $ 723  
     Interest cost
    1,648       1,937  
     Expected return on plan assets
    (1,483 )     (2,179 )
     Amortization of prior service cost
    -       4  
     Recognized actuarial (gain) or loss
    339       (9 )
     Net periodic benefit cost
  $ 892     $ 476  

   
Postretirement Costs
 
   
Three Months Ended
 
   
March 27,
   
March 28,
 
(In thousands)
 
2009
   
2008
 
Components of Net Periodic Benefit Cost:
           
Service cost
  $ 82     $ 187  
Interest cost
    315       367  
Amortization of prior service cost
    15       11  
Recognized actuarial (gain) or loss
    2       -  
Net periodic benefit cost
  $ 414     $ 565  

The Company made cash contributions of approximately $4.1 million to its pension plans during the first three months of 2009. The Company estimates it will be required to make additional cash contributions to its pension plans during the remainder of the year of approximately $1.7 million.
 
 
13.  
 
Commitments, contingencies and guarantees

a.  
In December 1981, the Company formed a partnership with a supplier of raw materials which mines and processes sodium-based mineral deposits.  The Company purchases the majority of its sodium-based raw material requirements from the partnership.  This agreement terminates upon two years’ written notice by either company.  The Company has an annual commitment to purchase 240,000 tons of sodium-based raw materials at the prevailing market price.  The Company is not engaged in any other material transactions with the partnership or the Company’s partner.

b.  
Our distribution of condoms under the TROJAN and other trademarks is regulated by the U.S. Food and Drug Administration (“FDA”).  Certain of our condoms, and similar condoms sold by our competitors, contain the spermicide nonoxynol-9 (“N-9”).  Some interested groups have issued reports that N-9 should not be used rectally or for multiple daily acts of vaginal intercourse.  In late 2008, the FDA issued final labeling guidance for latex condoms but excluded N-9 lubricated condoms from the guidance.  While we await further FDA guidance on N-9 lubricated condoms, we believe that our present labeling for condoms with N-9 is compliant with the overall objectives of the FDA’s guidance, and that condoms with N-9 will remain a viable contraceptive choice for those couples who wish to use them.  However, we cannot predict the nature of the labeling that ultimately will be required by the FDA. If the FDA or state governments eventually promulgate rules that prohibit or restrict the use of N-9 in condoms (such as new labeling requirements), we could incur costs from obsolete products, packaging or raw materials, and sales of condoms could decline, which, in turn, could decrease our operating income.

c.  
As of March 27, 2009, the Company had commitments to acquire approximately $112.1 million of raw material, packaging supplies and services from its vendors at market prices.  The packaging supplies are in either a converted or non-converted status.  These commitments enable the Company to respond quickly to changes in customer orders or requirements.

d.  
The Company has $3.3 million of outstanding letters of credit drawn on several banks which guarantee payment for such things as insurance claims in the event of the Company’s insolvency.  In addition, the Company guarantees the payment of rent on a leased facility in Spain.  The lease expires in November 2012 and the accumulated monthly payments from March 27, 2009 through the remainder of the lease term will amount to approximately $2.7 million.  Approximately two thirds of the rental space is subleased to a third party.

e.  
In connection with the Company’s acquisition of Unilever’s oral care brands in the United States and Canada in October 2003, the Company is required to make additional performance-based payments of a minimum of $5.0 million and a maximum of $12.0 million over the eight year period following the acquisition.  The Company made cash payments of $0.2 million, and accrued a payment of $0.2 million in the first three months of 2009.  The payment and accrual were accounted for as additional purchase price.  The Company has paid approximately $9.2 million, exclusive of the $0.2 million accrual, in additional performance-based payments since the acquisition.
 
f.  
The Company filed suit against Abbott Laboratories, Inc. (“Abbott”) in April 2005 claiming infringement of certain patents resulting from Abbott’s manufacture and sale of its Fact Plus pregnancy diagnostic test kits.  Following a trial in February 2008, the jury found that the Company’s patents were valid and willfully infringed by Abbott during the period from April 1999 through September 2003 and awarded damages to the Company in the amount of $14.6 million. On June 23, 2008, the District Court issued an opinion finding that Abbott’s conduct had been willful and doubled the damages awarded to the Company to $29.2 million. There remain two post-trial motions filed by the Company with the District Court with respect to prejudgment interest and attorney’s fees. Abbott has filed an appeal of the verdict that has been deactivated pending a ruling on the post-trial motions. In June 2007, Abbott filed a separate suit against the Company claiming infringement of certain patents that are licensed to Abbott, also in relation to pregnancy diagnostic test kits.  The Company is vigorously defending that action.

g.  
The Company, in the ordinary course of its business, is the subject of, or a party to, various pending or threatened legal actions.  The Company believes that any ultimate liability arising from these actions will not have a material adverse effect on its financial position, results of operations and cash flows.
 
 
14.  
 
Related Party Transactions

The following summarizes the balances and transactions between the Company and each of two 50% owned entities, Armand Products Company (“Armand”) and The ArmaKleen Company (“ArmaKleen”):

   
Armand
   
ArmaKleen
 
   
Three Months Ended
   
Three Months Ended
 
   
March 27,
   
March 28,
   
March 27,
   
March 28,
 
(In millions)
 
2009
   
2008
   
2009
   
2008
 
Purchases
  $ 2.2     $ 2.8       -       -  
Sales
    -       -     $ 1.0     $ 1.3  
Outstanding Accounts Receivable
  $ 0.3     $ 0.8     $ 0.9     $ 1.0  
Outstanding Accounts Payable
  $ 0.3     $ 1.1       -       -  
Administration & Management Oversight Services (1)
  $ 0.4     $ 0.4     $ 0.7     $ 0.7  
                                 
(1) Recorded as a reduction of selling, general and administrative expenses.
                 

15.  
Sale of Subsidiaries and Assets Held for Sale

On February 29, 2008, the Company sold its wholly-owned British subsidiary, Brotherton Speciality Products Ltd. (“Brotherton”), for $11.2 million, net of fees.  The sale resulted in a pretax gain of $3.0 million, which was recorded as a reduction of selling, general and administrative (“SG&A”) expenses in the Specialty Products Division Segment.

The Company has made available for sale certain non core personal care product lines. The results of these product lines are included in both the Consumer Domestic and Consumer International Segments. The Company anticipates proceeds of approximately $30 million, which is included in other current assets on the Company’s Consolidated Balance Sheet. The Company does not expect to record a gain or loss on the sale.
 
 
16.  
 
Plant Shutdown

On June 5, 2008, the Company announced plans to construct a new integrated laundry detergent manufacturing plant and distribution center in York County, Pennsylvania. Construction began in September 2008, and the facility is scheduled to be operational by the end of 2009.  The Company expects to invest approximately $151.0 million in capital expenditures to build the York County facility, of which $51.0 million was spent in 2008 and $14.7 million was spent in the first quarter of 2009.

In conjunction with the opening of the new facility, the Company will close its existing laundry detergent manufacturing plant and distribution facility in North Brunswick, New Jersey.  The Company plans to provide severance and transition benefits to approximately 270 affected employees at the North Brunswick complex, as well as consideration for employment opportunities at other Company operations.

The Company expects to incur the following cash and non–cash costs relating to the closing of the North Brunswick complex, which has been, or will be, included in cost of sales for the Consumer Domestic segment:

Cash Costs
Severance - $4.2 million
Exit and disposal costs - $6.6 million

Non Cash Costs
Accelerated Depreciation - $24.6 million

The severance costs are being recognized ratably over the employees’ respective service requirement. In 2008, the Company accrued $1.9 million for severance costs. In the first quarter of 2009, the Company accrued an additional $0.5 million for severance costs. The exit and disposal costs include asset disposition and lease related costs. The Company anticipates it will incur approximately $3.0 million in exit and disposal costs in 2009 and the balance of the exit and disposal costs in 2010.

Accelerated depreciation charges are being recognized ratably over the remaining life of the North Brunswick complex. The Company recorded a charge of $8.1 million related to accelerated depreciation in 2008 and $4.5 million in the first quarter of 2009.

17.  
Segment Information

The Company operates three reportable segments: Consumer Domestic, Consumer International and Specialty Products Division (“SPD”).  These segments are determined based on differences in the nature of products and organizational and ownership structures.  The Company also has a Corporate segment.

Segment revenues are derived from the sale of the following products:

 
Segment
Products
 
Consumer Domestic
Household and personal care products
 
Consumer International
Primarily personal care products
 
SPD
Specialty chemical products
 
 
The Company had 50% ownership interests in Armand and ArmaKleen as of March 27, 2009.  The Company’s 50% ownership interest in Esseco U.K. LLP (“Esseco”) was divested in the first quarter of 2008 as part of the sale of Brotherton.  The equity in earnings of Armand and ArmaKleen for the three months ended March 27, 2009 and March 28, 2008, and Esseco for the two months ended February 29, 2008 (prior to the sale of Brotherton), is included in the Corporate segment.

Some of the subsidiaries that are included in the Consumer International segment manufacture and sell personal care products to the Consumer Domestic segment.  These sales are eliminated from the Consumer International segment results set forth below.

Segment sales and income before income taxes for the three months ended March 27, 2009 and March 28, 2008 were as follows:

(In thousands)
 
Consumer
Domestic
   
Consumer
International
   
SPD
   
Corporate
   
Total
 
Net Sales(1)
                             
First Quarter 2009
  $ 438,090     $ 82,760     $ 60,017     $ -     $ 580,867  
First Quarter 2008
    382,744       99,694       70,429       -       552,867  
Income Before Income Taxes(2)
                                       
First Quarter 2009
  $ 79,934     $ 10,717     $ 6,136     $ 2,705     $ 99,492  
First Quarter 2008
    67,831       7,252       9,941       2,380       87,404  

(1)  
Intersegment sales from Consumer International to Consumer Domestic, which were $0.5 million and $2.1 million for the first quarter ended March 27, 2009 and March 28, 2008, respectively, are not reflected in the table.

(2)  
In determining Income Before Income Taxes, interest expense, investment earnings, and other income (expense) were allocated among the segments based upon each segment’s relative operating profit. The Corporate segment income consists of equity in earnings of affiliates.

The following table sets forth product line revenues from external customers for the three months ended March 27, 2009 and March 28, 2008.

   
Three Months Ended
 
   
March 27,
   
March 28,
 
(In thousands)
 
2009
   
2008
 
Household Products
  $ 284,050     $ 242,827  
Personal Care Products
    154,040       139,917  
Total Consumer Domestic
    438,090       382,744  
Total Consumer International
    82,760       99,694  
Total SPD
    60,017       70,429  
Total Consolidated Net Sales
  $ 580,867     $ 552,867  
 
Household Products include deodorizing and cleaning products and laundry products. Personal Care Products include condoms, pregnancy kits, oral care and skin care products.

 
ITEM 2.                      MANAGEMENT’S DISCUSSION AND ANALYSIS

Results of Operations

Consolidated Results

Net Sales

Net Sales for the quarter ended March 27, 2009 were $580.9 million, an increase of $28.0 million or 5.1% above last year’s first quarter.  Of the increase, 4.5% is due to sales of products acquired in connection with the Company’s July 2008 acquisition of substantially all of the assets of Del Laboratories, Inc. (the “Orajel Acquisition”), partially offset by the loss of sales due to the divestiture in the first quarter of 2008 of Brotherton Speciality Products Ltd. (“Brotherton”), a former United Kingdom subsidiary that was included in the Company’s Specialty Products Division, and the third quarter 2008 divestiture of the Company’s consumer products subsidiary in Spain.  Foreign exchange rates reduced the current quarter sales by 4.1%. The balance of the increase in Net Sales is primarily due to higher prices, sales mix and higher unit volumes.

Operating Costs

The Company’s gross profit was $249.4 million for the quarter ended March 27, 2009, a $25.3 million increase as compared to the same period in 2008.  Gross margin increased 240 basis points to 42.9% in the first quarter as compared to 40.5% in the same quarter last year. The increase in gross margin includes higher margins associated with the sales of products acquired in the Orajel Acquisition, lower commodity costs, the impact of higher prices, liquid laundry detergent concentration and the benefits of cost reduction programs. The gross profit increase was partially offset by a $5.2 million charge related to the planned closing of an existing manufacturing facility (see Note 16 to the condensed consolidated financial statements included in this report) and the impact of foreign exchange rates.
 
Marketing expenses were $66.4 million in the first quarter, an increase of $12.9 million as compared to the same period in 2008. The increased marketing spending included expenditures for products acquired in the Orajel Acquisition.   Expenses for the Company's existing products increased in support of ARM & HAMMER liquid laundry detergent, OXICLEAN powder and liquid laundry additives and ARM & HAMMER dental care products. Marketing expense as a percentage of net sales increased 170 basis points to 11.4% in the first quarter as compared to 9.7% in last year’s first quarter.
 
Selling, general and administrative expenses (“SG&A”) were $78.3 million in the first quarter of 2009, an increase of $0.5 million as compared to the same period in 2008.  The year over year increase reflected higher operating expenses in 2009, principally to support higher sales, increased information systems costs and  amortization and operating costs related to the Orajel Acquisition, offset by foreign exchange rate changes.  In addition, SG&A for the first quarter of 2008 included asset impairment charges of $5.6 million and a higher level of legal costs, primarily due to litigation against Abbott Laboratories (see paragraph f in Note 13 to the condensed consolidated financial statements included in this report) as well as a $3.0 million gain on the divestiture of Brotherton.
 
Other Income and Expense
 
Other income was approximately $0.5 million in the first quarter of 2009 as compared to $2.2 million in the same period of 2008. The change is primarily due to lower foreign exchange gains.
 
Interest expense in the three month period ended March 27, 2009 decreased $3.8 million compared to the same period in 2008. The decline was due to lower interest rates compared to the prior year partially offset by higher average debt outstanding as a result of the Orajel acquisition.

Investment income in the three month period ended March 27, 2009 decreased $2.2 million due to lower interest rates, although there was a higher average cash balance for investment as compared to the same period in 2008.

 
Taxation

The effective tax rate in the first quarter of 2009 was 37.1% compared to 35.7% in the prior year’s first quarter. The increase in the effective tax rate results from a higher proportion of projected U.S. taxable income and higher state taxes.

Segment Results

The Company operates three reportable segments: Consumer Domestic, Consumer International and Specialty Products Division (“SPD”).  These segments are determined based on differences in the nature of products and organizational and ownership structures.  The Company also has a Corporate segment.
 
 
Segment
Products
 
Consumer Domestic
Household and personal care products
 
Consumer International
Primarily personal care products
 
SPD
Specialty chemical products
 
The Company had 50% ownership interests in Armand Products Company (“Armand”) and The ArmaKleen Company (“ArmaKleen”) as of March 27, 2009.  The Company’s 50% ownership interest in Esseco U.K. LLP (“Esseco”) was divested in the first quarter of 2008 as part of the sale of Brotherton. The equity in earnings of Armand and ArmaKleen for the three months ended March 27, 2009 and March 28, 2008, and Esseco for the two months ended February 29, 2008 (prior to the sale of Brotherton), is included in the Corporate segment.

Some of the subsidiaries that are included in the Consumer International segment manufacture and sell personal care products to the Consumer Domestic segment.  These sales are eliminated from the Consumer International segment results set forth below.

Segment sales and income before income taxes for the three month period ended March 27, 2009 and March 28, 2008 were as follows:

   
Consumer
   
Consumer
                   
(In thousands)
 
Domestic
   
International
   
SPD
   
Corporate
   
Total
 
Net Sales(1)
                             
First Quarter 2009
  $ 438,090     $ 82,760     $ 60,017     $ -     $ 580,867  
First Quarter 2008
    382,744       99,694       70,429       -       552,867  
Income Before Income Taxes(2)
                                       
First Quarter 2009
  $ 79,934     $ 10,717     $ 6,136     $ 2,705     $ 99,492  
First Quarter 2008
    67,831       7,252       9,941       2,380       87,404  
 
(1)  
Intersegment sales from Consumer International to Consumer Domestic, which were $0.5 million and $2.1 million for the first quarter ended March 27, 2009 and March 28, 2008, respectively, are not included in the table.
 
(2)  
In determining Income Before Income Taxes, interest expense, investment earnings, and other income (expense) were allocated among the segments based upon each segment’s relative operating profit. The Corporate segment income consists of equity in earnings of affiliates.
 
 
Product line revenues for external customers for the three months ended March 27, 2009, and March 28, 2008, were as follows:
 
   
Three Months Ended
 
   
March 27,
   
March 28,
 
(In thousands)
 
2009
   
2008
 
Household Products
  $ 284,050     $ 242,827  
Personal Care Products
    154,040       139,917  
Total Consumer Domestic
    438,090       382,744  
Total Consumer International
    82,760       99,694  
Total SPD
    60,017       70,429  
Total Consolidated Net Sales
  $ 580,867     $ 552,867  

Consumer Domestic

Consumer Domestic net sales in the first quarter of 2009 were $438.1 million, an increase of $55.3 million or  14.5% as compared to the first quarter of 2008.  Of the increase, approximately 6% relates to sales of products acquired in the Orajel Acquisition, with the remainder principally attributable to higher unit volumes, with the balance due to higher prices and mix. At a product line level, sales of XTRA liquid laundry detergent, ARM & HAMMER liquid laundry detergent, OXICLEAN laundry additive, ARM & HAMMER powder laundry detergent and ARM & HAMMER SUPER SCOOP cat litter were all higher than in the first quarter of 2008. Consumer Domestic net sales benefited from the May 2008 price increase on ARM & HAMMER powder laundry detergent and the October 2008 price increase on liquid laundry detergents, toothpaste and battery operated toothbrushes. The increased net sales were offset partially by lower sales of household cleaners and certain personal care products.

Consumer Domestic Income Before Income Taxes for the first quarter of 2009 was $79.9 million, a $12.1 million increase as compared to the first quarter of 2008. The impact of higher net sales, the shift to concentrated liquid laundry detergent, the Orajel Acquisition, lower commodity costs and lower allocated interest expense was offset partially by accelerated depreciation and other expenses associated with the Company’s planned 2009 shutdown of its North Brunswick, New Jersey facility (see Note 16 to the condensed consolidated financial statements included in this report), and increased marketing and SG&A costs.

Consumer International

Consumer International net sales were $82.8 million in the first quarter of 2009, a decrease of $16.9 million or approximately 17.0% as compared to the first quarter of 2008. This decrease includes the impact of unfavorable foreign exchange rates of approximately 20% and the divestiture of the subsidiary in Spain at the end of the third quarter of 2008, partially offset by lower trade promotion costs and sales increases which occurred primarily in Canada and Australia.

Consumer International Income Before Income Taxes was $10.7 million in the first quarter of 2009, an increase of $3.5 million as compared to the first quarter of 2008. The increase includes higher prices in 2009.  In addition, results for the first quarter of 2008 reflected asset impairment charges of $5.6 million and severance costs in one of the Company’s European subsidiaries.

Specialty Products Division (SPD)

Specialty Products net sales were $60.0 million in the first quarter of 2009, a decrease of $10.4 million or 14.8% as compared to the first quarter of 2008. This decrease in net sales includes the approximately 5% impact of unfavorable foreign exchange rates and the approximately 6% impact of the sale of Brotherton during the first quarter of 2008.  A significant decline in U.S. milk prices weakened the dairy market resulting in lower sales volumes in the animal nutrition business, partially offset by higher prices of certain specialty chemical products.

Specialty Products Income Before Income Taxes was $6.1 million in the first quarter of 2009, a decrease of $3.8 million as compared to the first quarter of 2008. The 2008 results included a $3.0 million gain associated with the sale of Brotherton. In addition, the balance of the decrease reflects lower sales, higher raw material costs for certain animal nutrition and specialty chemical products and higher SG&A expense.

 
Liquidity and Capital Resources
 
As of March 27, 2009, the Company had $280.2  million in cash, $85.0 million available through its $115.0 million accounts receivable securitization facility, approximately $96.0 million available under its $100.0 million revolving credit facility and a $250.0 million accordion feature that enables the Company to increase the principal amount of its term loan. To ensure the safety of its cash resources, the Company invests its cash primarily in government agency money market funds.
 
The Company renewed its accounts receivable securitization facility in February 2009. This facility has been renewed annually and the Company anticipates that this facility will be renewed in February 2010.
 
The Company believes that its ability to access the sources of cash described above has not been adversely affected by recent economic events. Therefore, the Company currently does not anticipate that the credit environment will have a material adverse effect on its ability to address its current and forecasted liquidity requirements. The Company anticipates that its cash from operations, along with its current borrowing capacity, will be sufficient to meet its capital expenditure program costs (including the cash requirements related to construction of its new laundry detergent and warehouse facility in York County, Pennsylvania, discussed in this section under “Net Cash Used in Investing Activities”), pay its common stock dividend at current rates and meet its mandatory debt repayment schedule and minimum pension funding requirements over the next twelve months. Nevertheless, the current economic environment presents risks that could have adverse consequences that the Company does not currently anticipate will occur. For further information, see “Economic conditions could adversely affect our business” under “Risk Factors” in Item 1A of the Company’s Annual Report on Form 10-K for the year ended December 31, 2008.
 
In addition, the Company does not anticipate that current economic conditions will adversely affect its ability to comply with the financial covenants in its principal credit facilities because the Company currently is, and anticipates that it will continue to be, above the minimum interest coverage ratio requirement and below the maximum leverage ratio requirement. These ratios are discussed in more detail in this section under the sub-heading, “Adjusted EBITDA.”

Net Debt

The Company had outstanding total debt of $871.2 million and cash of $280.2 million (of which approximately $41.7 million resides in foreign subsidiaries) at March 27, 2009.  Total debt less cash (“net debt”) was $591.0 million at March 27, 2009. This compares to total debt of $856.1 million and cash of $198.0 million, resulting in net debt of $658.1 million at December 31, 2008.

The Company entered into two cash flow hedge agreements each covering $100.0 million of zero cost collars, one effective as of September 29, 2006, and the other effective as of December 29, 2006, to reduce the impact of interest rate fluctuations on its term loan debt.  The hedge agreements have terms of five and three years, respectively, each with a cap of 6.50% and a floor of 3.57%. The Company recorded a charge to interest expense of $1.0 million in the first quarter of 2009 with respect to the hedge agreements. Changes in the fair value of the hedge agreements are recorded in Accumulated Other Comprehensive Income on the balance sheet.

Cash Flow Analysis
 
   
Three Months Ended
 
   
March 27,
   
March 28,
 
(In thousands)
 
2009
   
2008
 
Net cash provided by operating activities
  $ 91,981     $ 62,723  
Net cash (used in) provided by investing activities
  $ (20,615 )   $ 4,184  
Net cash provided by (used in) financing activities
  $ 11,714     $ (108,834 )

Net Cash Provided by Operating Activities – The Company’s net cash provided by operating activities in the first three months of 2009 increased $29.3 million to $92.0 million as compared to the same period in 2008. The increase was primarily due to higher net income, higher non-cash expenses for depreciation and a smaller increase in working capital (exclusive of cash), partially offset by the gain recorded on the sale of Brotherton (see Note15) as well as the asset impairment write-offs recorded in the first quarter of 2008.

 
For the three months ending March 27, 2009, the components of working capital that significantly affected operating cash flow are as follows:
 
 
Accounts receivable increased $8.0 million due to business growth.
 
 
Inventories increased $2.4 million primarily to support higher anticipated sales.
 
 
Accounts payable and other accrued expenses decreased $11.8 million primarily due to the timing of incentive and profit sharing payments which were offset partially by increased marketing expense accruals.
 
 
Taxes payable increased $20.4 million due to higher tax expense associated with increased earnings and the timing of payments.

Net Cash Used in Investing Activities – Net cash used in investing activities during the first three months of 2009 was $20.6 million, reflecting $21.3 million of property, plant and equipment expenditures (including $14.7 million for the York County plant, discussed in the following paragraph), partially offset by a $1.3 million payment received on an outstanding note.

On June 5, 2008, the Company announced plans to construct a new laundry detergent manufacturing plant and distribution center in York County, Pennsylvania and to close its existing laundry detergent manufacturing and distribution facility in North Brunswick, New Jersey.  The Company anticipates that capital expenditures in connection with construction of the new facility, which is expected to be operational by the end of 2009, will be approximately $151 million, and cash expenditures relating to the closing of the North Brunswick facilities will be approximately $11 million. To build the plant and distribution center, the Company spent approximately $51 million in 2008, and approximately $15 million in the first quarter of 2009, and anticipates spending an additional $85 million in the remainder of 2009.   The Company estimates it also will spend approximately $3 million in 2009 and $8 million in 2010 in connection with closing the North Brunswick facility.  The costs will be funded using the Company’s existing credit facilities and available cash. See Note 16 to the condensed consolidated financial statements included in this report for additional information.

Net Cash Provided by Financing Activities – Net cash provided by financing activities during the first three months of 2009 was $11.7 million. This reflects a net increase in debt of $15 million. An increase in short term borrowings of $29.0 million associated with  the Company’s accounts receivable securitization facility and increases in international debt of $3.0 million, were partially offset by mandatory payments on the Term Loan of $17.0 million. Payments of cash dividends of $6.3 million were offset partially by proceeds of and tax benefits from stock option exercises of $3.0 million.

Adjusted EBITDA

Adjusted EBITDA is a component of the financial covenants contained in the Company's primary credit facility.  Management believes that the presentation of Adjusted EBITDA is useful to investors as a financial indicator of the Company's ability to service its indebtedness. Adjusted EBITDA may not be comparable to similarly titled measures used by other entities and should not be considered as an alternative to cash flows from operating activities, which is determined in accordance with accounting principles generally accepted in the United States.  Financial covenants include a total debt to Adjusted EBITDA leverage ratio and an interest coverage ratio, which if not met, could result in an event of default and trigger the early termination of the credit facility, if not remedied within a specified period of time. The leverage ratio (total debt to Adjusted EBITDA) was 1.9, which is below the maximum of 3.5 permitted under the credit facility, and the interest coverage ratio (Adjusted EBITDA to total interest expense) for the first quarter of 2009 was 10.8, which is above the minimum of 3.0 permitted under the credit facility.  The Company’s obligations under the credit facility are secured by the assets of the Company.

Recent Accounting Pronouncements

In December 2008, the FASB issued FASB Staff Position No. SFAS 132(revised 2003)-1, “Employers’ Disclosures about Postretirement Benefit Plan Assets” (FSP FAS 132(R)-1), which requires employers to disclose information about fair value measurements of plan assets that are similar to the disclosures about fair value measurements required by SFAS No 157, “Fair Value Measurements” (“SFAS 157”).  FSP FAS 132(R)-1 will become effective for the Company’s annual financial statements for 2009.  The Company currently is evaluating the impact of this standard on our Consolidated Financial Statements.

In April 2009, the FASB issued FASB Staff Position No SFAS 107-1 and APB No. 28-1, “Disclosures about the Fair Value of Financial Instruments” (“FSP FAS 107-1 and APB 28-1”), which requires quarterly disclosure of information about the fair value of financial instruments within the scope of FASB Statement No.107, “Disclosures about Fair Value of Financial Instruments.” FSP FAS 107-1 and APB 28-1 have an effective date requiring adoption for the Company’s second quarter Form 10-Q.

 
ITEM 3.                      QUANTITATIVE AND QUALITATIVE DISCLOSURE ABOUT MARKET RISK

Interest Rate Risk
 
The Company had outstanding total debt at March 27, 2009 of $871.2 million, of which $250.0 million or 29% carries a fixed rate of interest. The remaining debt balance is primarily comprised of $586.0 million in term loans under the Company’s principal credit facilities, $30.0 million outstanding under a receivables purchase agreement and $5.2 million in international debt. The weighted average interest rate on these borrowings at March 27, 2009, excluding deferred financing costs and commitment fees, was approximately 3.4%.

The Company entered into two cash flow hedge agreements, each covering $100.0 million of zero cost collars, one effective as of September 29, 2006, and the other effective as of December 29, 2006, to reduce the impact of interest rate fluctuations on its term loan debt.  The hedge agreements have terms of five and three years, respectively, each with a cap of 6.50% and a floor of 3.57%. The Company recorded a charge to interest expense of $1.0 million in the first quarter of 2009 and estimates it will recognize approximately $2.8 million in interest expense in the remainder of 2009 with respect to the hedge agreements.  Changes in the hedging options’ fair value are recorded in Accumulated Other Comprehensive Income on the balance sheet.

If the variable rate on the Company’s floating rate debt outstanding on March 27, 2009 were to change by 100 basis points from the March 27, 2009 level, annual interest expense associated with the floating rate debt would change by approximately $4.2 million.
 
Foreign Currency
 
The Company is subject to exposure from fluctuations in foreign currency exchange rates, primarily U.S. Dollar/Euro, U.S. Dollar/British Pound, U.S. Dollar/Canadian Dollar, U.S. Dollar/Mexican Peso, U.S. Dollar/Australian Dollar, U.S. Dollar/Brazilian Real and U.S. Dollar/Chinese Yuan.

The Company, from time to time, enters into forward exchange contracts to hedge anticipated but not yet committed sales or purchases denominated in the U.S. Dollar, Canadian dollar, British pound and Euro. During the fourth quarter of 2008 and the first quarter of 2009, the Company’s Canadian subsidiary entered into  forward exchange contracts to protect the Company from the risk that dollar net cash outflows would be adversely affected by changes in exchange rates.  The contracts expire by the end of 2009. The face value of the unexpired contracts as of March 27, 2009 totaled $13.5 million.  The contracts qualified for hedge accounting in accordance with SFAS No. 133, and, therefore, changes in the fair value through the end of the first quarter 2009 were marked to market and recorded as Other Comprehensive Income. The gain recorded, net of deferred taxes was approximately $0.4 million.

Diesel Fuel Hedge

The Company uses independent freight carriers to deliver its products.  These carriers charge the Company a basic rate per mile that is subject to a mileage surcharge for diesel fuel price increases.  In July 2008 and April 2009, in response to increasing fuel prices and a concomitant increase in mileage surcharges, the Company entered into agreements with two providers to hedge approximately 36% if its notional diesel fuel requirements for 2009 and approximately 15% of its 2010 requirements.  It is the Company’s policy to use the hedges to mitigate the volatility of diesel fuel prices and related fuel surcharges, and not to speculate in the future price of diesel fuel.  The hedge agreements are designed to add stability to the Company’s product costs, enabling the Company to make pricing decisions and lessen the economic impact of abrupt changes in diesel fuel prices over the term of the contract.

Because the diesel hedge agreements do not qualify for hedge accounting under Statement of Financial Accounting Standards No. 133, “Accounting for Derivative Instruments and Hedging Activities,” the Company is required to mark the agreements to market throughout the life of the agreements.  The change in the market value of the hedge agreements resulted in a $0.1 million loss for the first quarter of 2009 which is reflected in cost of sales.  If future diesel prices were to change by $0.10 per gallon, the impact on the 2009 financial statements due to the hedge agreements would be approximately $0.2 million.
 
Equity Derivatives

The Company has entered into equity derivative contracts of its own stock in order to minimize the impact on earnings resulting from fluctuations in the liability to plan participants for contributions designated to notional investments in Company stock under the Company’s deferred compensation plan as a result of changes in quoted fair values.

 
ITEM 4.                      CONTROLS AND PROCEDURES

a.  
Evaluation of Disclosure Controls and Procedures

 
The Company’s management, with the participation of the Company’s Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of the Company’s disclosure control and procedures at the end of the period covered by this report.  Based on that evaluation, the Chief Executive Officer and Chief Financial Officer concluded that the Company’s disclosure controls and procedures as of the end of the period covered by this report are functioning effectively to provide reasonable assurance that the information required to be disclosed by the Company in reports filed under the Securities Exchange Act of 1934 is (i) recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and (ii) accumulated and communicated to the Company’s management, including the Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding the disclosure.

b.  
Change in Internal Control over Financial Reporting
 
 
No change in the Company’s internal control over financial reporting occurred during the Company’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting.
 
Cautionary Note on Forward-Looking Statements

This Report contains forward-looking statements, including, among others, statements relating to short- and long-term financial objectives, sales and earnings growth, earnings per share, margin improvement, price increases, marketing spending, the Orajel Acquisition, assets held for sale, the shift to concentrated liquid laundry detergent, the Company’s hedge programs, interest rate collars, effective tax rate, capital expenditures, the timing of the completion of the York County, Pennsylvania laundry detergent and warehouse facility, capital expenditures relating to the new facility, facility restructuring charges, the closing of the Company's facilities in North Brunswick, New Jersey, the sufficiency of cash flow to meet capital expenditures needs, the ability of the Company to comply with financial covenants, the effect of the credit environment on liquidity and the Company’s ability to renew the accounts receivable facility.  These statements represent the intentions, plans, expectations and beliefs of the Company, and are subject to risks, uncertainties and other factors, many of which are outside the Company’s control and could cause actual results to differ materially from such forward-looking statements.  Important factors that could cause actual results to differ materially from those in the forward-looking statements include a decline in market growth and consumer demand (including the effect of political, economic and marketplace conditions and events on consumer demand); unanticipated increases in raw material and energy prices; adverse developments affecting the financial condition of major customers; competition; the impact of retailer actions in response to changes in consumer demand and the economy, including increasing shelf space of private label products; consumer reaction to new product introductions and features; disruptions in the banking system and financial markets and the outcome of contingencies, including litigation, pending regulatory proceedings and environmental remediation. 

The Company undertakes no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise. You are advised, however, to consult any further disclosures we make on related subjects in our filings with the U.S. Securities and Exchange Commission.
 
 
PART II - OTHER INFORMATION
 
ITEM 1. LEGAL PROCEEDINGS

The Company, in the ordinary course of its business, is the subject of, or party to, various pending or threatened legal actions.  The Company believes that any ultimate liability arising from these actions will not have a material adverse effect on its financial position or results of operation.

ITEM 1A. RISK FACTORS

In addition to the other information set forth in this report, you should carefully consider the factors discussed in Item 1A, “Risk Factors” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2008, which could materially affect our business, financial condition or future results.
 
ITEM 4.   SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS

The Company’s Annual Meeting of Stockholders (the “Annual Meeting”) was held on April 30, 2009. The following nominees were elected to serve on the Company’s Board of Directors for a term of three years:
 
Nominees
 
For
 
Withheld
T. Rosie Albright
 
59,305,319
 
256,933
Ravichandra K. Saligram
 
59,309,249
 
253,003
Robert K. Shearer
 
59,106,758
 
455,494

The Company’s other directors whose term of office continued after the meeting are: James R. Craigie, Robert A. Davies, III, Rosina B. Dixon, M.D., Bradley C. Irwin, J. Richard Leaman, Jr., Robert D. LeBlanc and Arthur B. Winkleblack.  Robert A. McCabe and John O. Whitney retired from the Company’s Board of Directors, effective as of the Annual Meeting.

In addition to the election of three directors, stockholders voted on a proposal to ratify the appointment of Deloitte & Touche LLP as the independent registered public accounting firm to audit the Company’s 2009 consolidated financial statements.  The voting results on the proposal were as follows:

For
 
Against
 
Abstain
58,638,124
 
897,259
 
26,869

 
ITEM 6.                      EXHIBITS

(3.1)
Certificate of Amendment of Restated Certificate of Incorporation dated June 4, 2008, as filed with the Secretary of the State of Delaware on June 4, 2008.
     
 (3.2)
 Restated Certificate of Incorporation of the Corporation, as amended through June 4, 2008.
     
 
(3.3)
By-laws of the Company as amended, incorporated by reference to Exhibit 3.1 to the Company’s current report on Form 8-K filed on February 3, 2009.
     
(11)
Computation of earnings per share.
     
(31.1)
Certification of the Chief Executive Officer of the Company pursuant to Rule 13a-14(a) under the Securities Exchange Act.
     
(31.2)
Certification of the Chief Financial Officer of the Company pursuant to Rule 13a-14(a) under the Securities Exchange Act.
     
(32.1)
Certification of the Chief Executive Officer of the Company pursuant to Rule 13a-14(b) under the Exchange Act and 18 U.S.C. Section 1350.
     
(32.2)
Certification of the Chief Financial Officer of the Company pursuant to Rule 13a-14(b) under the Exchange Act and 18 U.S.C. Section 1350.
     
     
 
•  
Indicates documents filed herewith.
 
 
 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.


     
CHURCH & DWIGHT CO., INC.
     
(REGISTRANT)
       
DATE:
May 5, 2009
 
/s/ Matthew T. Farrell
     
MATTHEW T. FARRELL
     
CHIEF FINANCIAL OFFICER
       
DATE:
May 5, 2009
 
/s/ Steven J. Katz
     
STEVEN J. KATZ
     
VICE PRESIDENT AND
     
CONTROLLER
     
(PRINCIPAL ACCOUNTING OFFICER)

 
 
EXHIBIT INDEX
 
(3.1)
Certificate of Amendment of Restated Certificate of Incorporation dated June 4, 2008, as filed with the Secretary of the State of Delaware on June 4, 2008.
     
 (3.2)
 Restated Certificate of Incorporation of the Corporation, as amended through June 4, 2008.
     
 
(3.3)
By-laws of the Company as amended, incorporated by reference to Exhibit 3.1 to the Company’s current report on Form 8-K filed on February 3, 2009.
     
(11)
Computation of earnings per share.
     
(31.1)
Certification of the Chief Executive Officer of the Company pursuant to Rule 13a-14(a) under the Securities Exchange Act.
     
(31.2)
Certification of the Chief Financial Officer of the Company pursuant to Rule 13a-14(a) under the Securities Exchange Act.
     
(32.1)
Certification of the Chief Executive Officer of the Company pursuant to Rule 13a-14(b) under the Exchange Act and 18 U.S.C. Section 1350.
     
(32.2)
Certification of the Chief Financial Officer of the Company pursuant to Rule 13a-14(b) under the Exchange Act and 18 U.S.C. Section 1350.
     
     
 
•  
Indicates documents filed herewith.
 
- 31 -